Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment
- 22 May 2002
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (3) , 955-956
- https://doi.org/10.1016/s0041-1345(02)02714-8
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Treatment of post-transplant lymphoproliferative disorder with monoclonal cd20 antibody (rituximab) after heart transplantationThe Journal of Heart and Lung Transplantation, 2001
- TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER WITH THE ANTI-CD20 MONOCLONAL ANTIBODY RITUXIMAB ALONE IN AN ADULT AFTER LIVER TRANSPLANTATIONTransplantation, 2000
- Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantationThe Lancet, 1999
- Epstein-Barr Virus Infections in Children After Transplantation of the Small IntestineThe American Journal of Surgical Pathology, 1998